![]() |
|
|
DepressionReferencesAnderson IM, Tomensen BM. Treatment discontinuation with selective Bakish D, Habib R, Hooper CL. Mixed anxiety and Benfield P, Heel RC, Lewis SP. Prozac. Drugs 1986; 481-508. Berber MJ. FINISH: remembering the discontinuation syndrome. J Clin Psychiatry 1998; 59: 255. Borkovec TD, Costello E. Efficacy of applied relaxation and Boyer WF, Feighner JP. Safety and tolerability of SSRIs. In: Feighner JP, Boyer WF, eds. Deakin, JFW. Does selectivity matter? Int Clin Psychopharmacol 1996; 11 (Suppl 1): 13-17. Faverin data sheet. ABPI Data Sheet Compendium 1994-5. Jefferson JW. Antidepressants in Jönson B, Bebbington P. Economic studies of the treatment of depressive illness. In: Jönson B, Rosenbaum J, eds. Health economics of Joubert A, Sanchez C, Larsen F. Citalopram. Hum Psychopharmacol 2000; 15: 439-51. Lustral data sheet. ABPI Data Sheet Compendium 1994-5. Montgomery SA, Kasper S. Noyes R, Garvey MJ, Cook BL. Follow-up study of patients with Prozac data sheet. ABPI Data Sheet Compendium 1994-5. Schneier FR, Davies SO, Goetz D, et al. A controlled trial of moclobemide in Seroxat data sheet. ABPI Data Sheet Compendium 1994-5.
Last updated: 20.12.2011 |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||